Fund Details
Year Established
2016
Website
http://www.carb-x.orgHQ
Boston University School of Law,771e Commonwealth Avenue, Boston, Massachusetts, 02215, US, North America
HQ Phone
-
About
CARB-X (Combating Antibiotic Resistant Bacteria Accelerator) was launched in August 2016 to accelerate pre-clinical product development in the area of antibiotic-resistant infections, one of the world’s greatest health threats. CARB-X was established by BARDA and NIAID of the U.S. Department of Health and Human Services along with Wellcome Trust, a global charitable foundation dedicated to improving health. The CARB-X's goal is to move promising antibacterial candidates through the critical early stages of product development so they can attract additional private or public investment for clinical-stage development. CARB-X is headquartered at the Boston University School of Law.
HQ Map
No mappable locations available.
Sign up to see full fund details
Manager locations, team structure, and extended profile data for this investor.